Related references
Note: Only part of the references are listed.Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial
Kelly E. Dooley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
High prevalence of hepatitis C infection among multidrug-resistant tuberculosis patients
Kwonjune J. Seung et al.
JOURNAL OF HEPATOLOGY (2020)
Trends in Drug Resistance in Childhood Tuberculosis in Cape Town, South Africa
H. Simon Schaaf et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2020)
Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015
Ahmad Haeri Mazanderani et al.
PLOS ONE (2019)
Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis
Maria Musso et al.
BMC INFECTIOUS DISEASES (2019)
The burden of multidrug-resistant tuberculosis in children
H. E. Jenkins et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study
Polina A. Smirnova et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Adverse effects of oral second-line antituberculosis drugs in children
H. Simon Schaaf et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Elevated transaminases are common in children on prophylactic treatment for tuberculosis
Sara Leeb et al.
ACTA PAEDIATRICA (2015)
High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study
James A. Seddon et al.
THORAX (2014)
Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis
Kelly E. Dooley et al.
CLINICAL INFECTIOUS DISEASES (2012)
Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome
S. Keshavjee et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era
E. Palacios et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET INFECTIOUS DISEASES (2012)
Outcomes of Multidrug-Resistant Tuberculosis Treatment with Early Initiation of Antiretroviral Therapy for HIV Co-Infected Patients in Lesotho
Hind Satti et al.
PLOS ONE (2012)
Antituberculosis drug- induced hepatotoxicity in children
Peter R. Donald
PEDIATRIC REPORTS (2011)
Recruitment Maneuvers in ARDS ... More Questions Than Answers
Ajmal Khan et al.
CHEST (2010)
Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents
Katherine M. Coyne et al.
AIDS (2009)
Age- and Sex-related Reference Ranges of Alanine Aminotransferase Levels in Children: European Paediatric HCV Network
Kirsty England et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
The current state of serum biomarkers of hepatotoxicity
Josef Ozer et al.
TOXICOLOGY (2008)
Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children
H. S. Schaaf et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients
K Ohkawa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Share Paper
